Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations

摘要

The present invention relates to the use of RTPA to prevent the post-operative proliferation of lens tissues, known as secondary cataracts, on the posterior sheath well (fibrosis) after extracapsular cataract extraction.